Jason Napodano | TalkMarkets | Page 1


Latest Posts
1 to 2 of 2 Posts
MabVax Teams Up With Memorial Sloan Kettering To Develop CAR T Products
MabVax Therapeutics (Nasdaq: MBVX) announced it has entered into a sponsored research agreement with Memorial Sloan Kettering Cancer Center (MSK) for the development of novel Chimeric Antigen Receptor (CAR).
Want Fully Independent Biopharma Stock Research?
I am producing independent equity research on small-cap biotech and pharma names. The monthly price is only $50. Please check it out! Jason
1 to 2 of 2 Posts